News | September 04, 2013

Provision Center for Proton Therapy Selects RayStation

RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Provision Center for Proton Therapy. This partnership with Provision represents a milestone since it is the first proton center to select RayStation since RaySearch and IBA initiated a collaboration in the field of proton therapy earlier this year. 

Provision Center for Proton Therapy is one of only 14 proton therapy centers in the United States. Opening in early 2014, the Center is part of Provision Health Alliance's comprehensive outpatient cancer treatment campus located in Knoxville, Tenn. The comprehensive campus at Dowell Springs is both patient and physician-friendly and is the new model for future healthcare delivery. 

"The Provision Center for Proton Therapy is excited to be the one of the first proton therapy facilities in the United States to utilize RaySearch's advanced treatment planning system,” said Mary Lou DuBois, president of Provision Center for Proton Therapy. “RaySearch's innovative products, commitment to research and development, and strong collaborative approach to deliver high quality patient care perfectly aligns with our mission at Provision." 

RayStation will be implemented for clinical use at Provision Center for Proton Therapy beginning in the first quarter of 2014. This will include uniform scanning and passive scattering proton beam planning, IMRT for photons with multi-criteria optimization, as well as cutting edge technologies such as full deformable registration and adaptive re-planning. Pencil Beam Scanning (PBS) dose calculation capabilities that will allow for Intensity Modulated Proton Therapy (IMPT) will be introduced sometime in mid-2014. 

Niek Schreuder, vice president and chief medical physicist for Provision Center for Proton Therapy said: “The RayStation system offers a much needed improvement of the treatment planning environment for proton radiation therapy. Using the RayStation system will help us to improve our efficiency in producing highly optimized treatment plans for our patients and will offer advanced plan evaluation tools to the clinical team. We are excited to start using the system on our very first patients in January 2014.” 

Marc Mlyn, president of RaySearch Americas said: “We are excited to partner with Provision Center for Proton Therapy. Their state-of-the-art treatment center represents an ideal environment in which we can work together to enable efficient and ultra-modern patient care.” 

Johan Löf, CEO of RaySearch added: “In May we entered into a collaboration with the leading proton therapy equipment supplier IBA to further refine our treatment planning solution for proton treatments delivered with IBA systems. That collaboration enables us to provide the best proton treatment planning system on the market and I can't think of a better clinical partner than Provision to successfully implement these cutting edge technologies.” 

About Provision Center for Proton Therapy 
Opening in early 2014, the Provision Center for Proton Therapy will be the first of its kind in Tennessee and only the second in the Southeastern United States. Open to all credentialed physicians and health systems in the region, the Provision Center for Proton Therapy will have three treatment rooms and will be able to treat up to 1,000 cancer patients annually, and will bring in many patients from outside the area. The center brings to Knoxville an advanced cancer treatment capability that presently is available in only a handful of cities. Upon opening, it will be one of only 14 proton therapy centers in the nation. 

For more information:

Related Content

News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
Mercy Signs Multi-System, Multi-Hospital Agreement for Accuray Radiotherapy Systems
News | Radiation Therapy | May 16, 2018
Accuray Inc. signed a multi-system, multi-hospital agreement with Mercy for the acquisition of Accuray Radixact and...
ViewRay Unveils New Soft Tissue Visualization Technologies for MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | April 30, 2018
ViewRay Inc. announced new magnetic resonance imaging (MRI) technologies under development for its MRIdian Linac...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.
Technology | Quality Assurance (QA) | April 27, 2018
Sun Nuclear Corp. released significant new functionality for its SunCheck Platform for patient and machine quality...
RayStation Users Win Inaugural Treatment Planning World Championships
News | Treatment Planning | April 27, 2018
In the first World Championships of Treatment Planning, arranged by radiation oncology analytics company ProKnow and...
Brainlab Introduces New Hi-Res Planning Algorithm for VersaHD
News | Treatment Planning | April 24, 2018
Brainlab announced the implementation of a software solution that can achieve better radiation dose conformity around...
Shorter Radiotherapy Courses Safe and Effective for Prostate Cancer
News | Prostate Cancer | April 23, 2018
Radiotherapy given in high doses over a shorter period of time is safe and effective for prostate cancer patients,...
Elekta Expands Mosaiq Oncology Information System With PalabraApps
News | Oncology Information Management Systems (OIMS) | April 20, 2018
April 20, 2018 — Elekta announced that it is making a strategic investment in PalabraApps LLC to advance the developm
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
Overlay Init